As clinical development grows increasingly complex, the industry has recognized the critical role of centralized processes and risk‑based monitoring in ensuring high‑quality, reliable data. Regulatory ...
It’s why I make a point to do an inventory at least once a year with my spring cleaning. You never know what you’ll catch: a half-empty bottle of sinus medication from the ...
Reducing dampness through housing upgrades lowers respiratory medication use, offering strong evidence for health benefits of ...
Respiratory infectious diseases, such as viral pneumonia, pose a serious threat to global public health. These diseases spread rapidly and widely, potentially causing severe complications such as ...
AstraZeneca jumps 4% after COPD drug wins Phase 3 trials. Tozorakimab success seen as rare win in tough COPD drug race.
A man suffering from lung disease died after being prescribed the wrong medication for nearly four years. Daniel Noakes was ...
Connecticut has banned tianeptine, known as "gas station heroin," classifying it as Schedule I as 14 states crack down on the ...
Top-line results from the OBERON and TITANIA trials showed that tozorakimab reduced the annualised rate of moderate-to-severe ...
This clinical-stage biotech develops inhaled therapies for rare respiratory diseases, with its lead candidate in Phase III ...
Morocco’s medicines agency has launched an urgent recall of a batch of the neonatal drug Curosurf after detecting a potential microbial contamination risk that could affect patient safety in ...
Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but ...
Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results